Companies List
>> AmerisourceBergen
Amerisourcebergen Corporation (Amerisourcebergen) is a pharmaceutical services company, with operations in the United States, Canada and the United Kingdom. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services. It distributes an offering of brand name and generic pharmaceuticals, over-the-counter healthcare products, and home healthcare supplies and equipment to a variety of healthcare providers located in the United States and Canada, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order facilities, physicians, clinics and other alternate site facilities, and skilled nursing and assisted living centers. The Company operates in two business segments: Pharmaceutical Distribution and PharMerica.
Official website:
www.amerisourcebergen.com
|
|
 |
|
USA stock market daily report by Millenium Traders (October 9, 2008, Thursday, 10.30 p.m. GMT), 9 October 2008
USA stock market daily report by Millenium Traders (October 8, 2008, Wednesday, 10.30 p.m. GMT), 8 October 2008
USA stock market daily report by Millenium Traders (October 7, 2008, Tuesday, 10.30 p.m. GMT), 7 October 2008
|
|
Verint Systems price target reduced, 7 December 2007
Thomas Weisel upgraded Intel to "overweight", 6 December 2007
UBS upgraded price target on Exxon Mobil to $96, 21 November 2007
|
|
|
|
|
|
 |
|
Indian stock market morning report by Keynote Capitals (October 10, 2008, Friday, 7.00 a.m. GMT), 10 October 2008
Indian stock market morning report by Keynote Capitals (October 8, 2008, Wednesday, 7.00 a.m. GMT), 8 October 2008
Indian stock market morning report by Keynote Capitals (October 7, 2008, Tuesday, 6.00 a.m. GMT), 7 October 2008
|
|
Keynote Capitals maintain "buy" recommendation on Pyramid Saimira Theatre, 5 February 2008
Keynote Capitals recommends to buy Euro Ceramics Ltd., 5 February 2008
Keynote Capitals recommends to buy Pyramid Saimira Theatre, 13 December 2007
|
|
|
|
|
|
 |
|
Russian stock market morning report by Veles Capital (October 8, 2008, Wednesday, 7.30 a.m. GMT), 8 October 2008
Russian stock market morning report by Veles Capital (October 7, 2008, Tuesday, 7.30 a.m. GMT), 7 October 2008
Russian stock market morning report by Veles Capital (October 6, 2008, Monday, 7.30 a.m. GMT), 6 October 2008
|
|
Veles Capital upgraded price target on Rosneft from $14.31 to $15.11, recommendation "buy" unchanged, 18 September 2008
Veles Capital set price target of $5.75 on NLMK, recommenation - "buy", 17 September 2008
Veles Capital reduced price target on Lukoil from $138.44 to $129.63, recommendation "buy" unchanged, 15 September 2008
|
|
|
|
|
|
